Take the history
Previous filler, dates, product information, symptoms, photographs and treatment records are reviewed where available.
FILLER DISSOLVING · BURFORD, OXFORDSHIRE
Filler Dissolving
Assessment-led treatment for selected concerns involving hyaluronic-acid dermal filler.
Hyaluronidase can break down hyaluronic-acid filler, but dissolving should not be treated as a casual cosmetic reset. The first task is to identify what has been injected, what is causing the concern and whether dissolving is actually the safest or most useful next step.
01 · THE TREATMENT
Dissolving only makes sense when the material and the problem are understood.
Not every lump, contour change or asymmetry is filler migration.
Hyaluronidase is an enzyme used to break down hyaluronic acid. In aesthetic medicine it can be used in selected situations involving HA filler, including overcorrection, misplaced product and some filler-related complications.
Clinical assessment comes first because swelling, inflammation, infection, nodules, tissue change and non-HA filler can look similar from the outside. In some cases examination alone is enough; in others, imaging or a specialist complications pathway may be more appropriate before treatment.
01Identify
Previous product, timing, treatment area, symptoms and clinical findings are reviewed.
02Differentiate
Migration or overfilling is separated from swelling, inflammation, infection, nodules or another cause.
03Dissolve if appropriate
Hyaluronidase is used when the concern involves hyaluronic-acid filler and the benefit outweighs the risks.
04Reassess
The tissue is allowed to settle before deciding whether any further aesthetic treatment is needed.
02 · SUITABILITY
“I want it dissolved” is the start of the assessment, not the treatment plan.
The visible problem may be caused by product, swelling, inflammation, infection, tissue anatomy or a combination of these. Hyaluronidase only acts on hyaluronic acid and should not be used as a substitute for diagnosis.
01 MAY BE CONSIDERED
- Selected overcorrection or unwanted contour caused by confirmed or strongly suspected HA filler
- Migration or misplaced HA filler where reduction is clinically appropriate
- Selected non-emergency HA-filler complications where hyaluronidase forms part of the management plan
- Patients able to accept that tissue appearance may change once filler volume is reduced
02 ANOTHER ROUTE MAY FIT BETTER
- Unknown or non-hyaluronic-acid filler where hyaluronidase would not address the material
- Inflammation, infection or nodules requiring a different diagnostic or medical pathway
- Acute severe pain, skin colour change or visual symptoms requiring urgent complication management
- Normal anatomy or tissue laxity being mistaken for filler migration
VAIVA'S ASSESSMENT
The first question is not how much hyaluronidase to use. It is what we are treating.
The assessment looks at the previous filler, timing, symptoms, tissue behaviour and whether the problem is aesthetic, inflammatory, vascular or unrelated to the filler itself.
CLINICAL ASSESSMENTFiller Dissolving
Burford · West Oxfordshire · Cotswolds
01
Product history
Known filler type, brand where available, amount, area and date help establish whether hyaluronidase is relevant.
02
Symptoms & timing
Pain, swelling, colour change, tenderness, delayed inflammation and onset timing can change the urgency and pathway.
03
Clinical pattern
Overfilling, migration, oedema, nodules and normal anatomy are not assumed to be the same problem.
04
Imaging need
Ultrasound may be useful when filler type, location or the nature of a complication is uncertain.
05
Medical context
Allergy history, medicines, infection risk and previous complications are considered before treatment. Previous reactions to hyaluronidase and significant bee or wasp venom allergy are specifically relevant to elective risk assessment.
06
What happens after
The plan includes what the tissue may look like once volume is removed and whether waiting is preferable to immediate refilling.
CLINICAL DECISION PATHWAY
dissolve / image first / complications pathway / observe / refer / emergency care / no treatment
CLINICAL RESTRAINT
Hyaluronidase is treatment, not an aesthetic eraser.
identify the fillerdiagnose before treatingurgent symptoms escalatedose to the clinical goalallow tissue to settledo not refill automatically
03 · APPOINTMENT
An assessment appointment may end without dissolving.
That is a legitimate clinical outcome if the material is uncertain, the concern has another cause or a different pathway is safer.
Examine the area
Contour, swelling, skin changes, tenderness and tissue behaviour are assessed rather than assuming migration.
Decide the pathway
The outcome may be dissolving, imaging, observation, complications assessment, referral or urgent escalation.
Treat if appropriate
When HA filler is the problem, hyaluronidase is used according to the clinical objective rather than a one-dose-fits-all approach.
Reassess after settling
Further filler or corrective treatment is not planned until the tissue response can be judged properly.
04 · RESULTS & RECOVERY
The aim is to correct the problem, not to promise an exact return to a previous face.
0Treatment day
Redness, swelling, tenderness or bruising may occur after hyaluronidase injection.
HoursEarly response
Some HA filler reduction may become apparent relatively quickly, but swelling can obscure the true contour.
DaysSettling
The treated area should be allowed to settle before the result is judged.
ReviewReassess
Further dissolving, observation or another treatment is considered only after the clinical response is clear.
What we are looking for
The goal may be reduction of misplaced or unwanted HA filler, improvement in contour or treatment of a filler-related complication. The response depends on filler characteristics, amount, location, tissue and the clinical reason for dissolving.
Will one session be enough?
Not always. Controlled evidence for hyaluronidase dosing is limited and protocols vary by indication. Some situations may require staged reassessment rather than attempting complete correction in one appointment.
Important risks
Swelling, redness, tenderness, bruising and allergic or hypersensitivity reactions can occur. Hyaluronidase acts on hyaluronic acid in the treated area, including naturally occurring HA, but this should not be interpreted as permanent destruction of normal tissue. Emergency filler complications are managed differently from elective cosmetic dissolving and should never wait for a routine appointment.
05 · BEFORE & AFTERCARE
Allow the tissue to settle before deciding what comes next.
Aftercare depends on why hyaluronidase was used. Elective dissolving, inflammatory complications and emergency vascular events are not the same clinical pathway.
01
Prepare
Bring any information you have about previous filler, including product, amount, treatment area, dates and photographs.
02
Observe
Follow the aftercare advice given and allow swelling or bruising to settle before judging contour.
03
Escalate if needed
Seek urgent medical assessment for severe or increasing pain, unusual blanching or dusky skin colour, or any visual symptom.
SKIN APOTHECARY
Skincare cannot dissolve filler or treat a filler complication.
For this service, product selling is deliberately secondary. Skin products may support comfort later, but they should not delay clinical assessment or be presented as corrective treatment.
Explore medical skincare →Clinical assessment comes first.
If the concern follows previous filler, identify the problem before adding skincare, more filler or another procedure.
NOT SURE WHETHER THE PROBLEM IS FILLER?
Do not diagnose migration from a photograph alone.
Assessment may lead to dissolving, imaging, observation, referral or no treatment.
06 · CHOOSING THE PATHWAY
Dissolving, complications care and refilling are different decisions.
The correct next step depends on the material, symptoms, urgency and the reason the original result is unsatisfactory.
PathwayPurposeWhen it may be considered
Filler DissolvingHyaluronidase for selected HA-filler concernsWhen unwanted or misplaced hyaluronic-acid filler is identified and reduction is appropriate
Aesthetic Complications Assessment ↗Clinical assessment of a previous treatment concernWhen symptoms, inflammation, nodules, swelling or another complication require diagnosis before correction
Dermal Fillers ↗Structural HA filler treatmentOnly after tissues have settled and a new structural indication remains clear
Urgent careImmediate assessment of possible vascular or visual complicationsSudden severe pain, blanching or dusky colour, visual symptoms or rapidly worsening acute symptoms
07 · CLINICAL EVIDENCE
Hyaluronidase is established in HA-filler complication management, but diagnosis and dosing remain situation-specific.
A 2024 clinical review found increasing experience with hyaluronidase for HA-filler complications but limited controlled dosing data, with treatment intensity differing between elective concerns and emergencies. Much of current dosing and complication-management practice therefore draws on clinical guidance, observational evidence and expert recommendations rather than large comparative trials. A UK guideline for HA-filler vascular occlusion emphasises immediate recognition and prompt hyaluronidase treatment for suspected vascular compromise. Imaging evidence has also developed: a 2024 retrospective ultrasound study showed that clinically similar filler complications can have different underlying patterns, and a 2026 literature review described high-frequency ultrasound with Doppler as useful for identifying filler type, location and complications such as migration, overfilling, granulomatous reactions and vascular compromise. The practical conclusion is that hyaluronidase is useful when the problem involves HA filler, but it should follow clinical diagnosis rather than assumption.
01Hyaluronidase for Dermal Filler ComplicationsClinical review · applications & dosage · 2024
02Guideline for the Management of HA Filler-Induced Vascular OcclusionClinical guideline · vascular occlusion
03Ultrasonographic Features of Nonvascular HA-Filler ComplicationsRetrospective study · 2024
04Ultrasonographic Evaluation of Cosmetic FillersLiterature review · 2026
08 · LONGER-TERM PLANNING
Dissolving does not create an obligation to refill.
Once tissues have settled, the next step may be observation, no treatment, a different treatment mechanism or carefully planned filler. A new syringe should not be the automatic conclusion of a dissolving appointment.
09 · FAQs
Questions about filler dissolving.
Can all dermal filler be dissolved?
No. Hyaluronidase acts on hyaluronic acid. Other filler materials, including calcium-hydroxylapatite and poly-L-lactic acid products, behave differently and are not simply dissolved with hyaluronidase.
How do I know if my filler has migrated?
Migration is one possible explanation for a contour change, but swelling, overfilling, oedema, nodules and normal anatomy can look similar. Examination, treatment history and sometimes ultrasound are more reliable than diagnosing migration from appearance alone.
Will hyaluronidase remove all of my filler?
Not necessarily. The response depends on the filler, amount, location, clinical objective and dose. Some concerns are managed with targeted reduction rather than trying to remove every trace of HA filler.
Is filler dissolving an emergency treatment?
It can be. Hyaluronidase is used in emergency management of suspected HA-filler vascular occlusion, but that is different from routine elective dissolving. Sudden severe pain, skin colour change or visual symptoms require immediate clinical assessment rather than waiting for a standard appointment.
Can I refill straight after dissolving?
Usually the tissue should be allowed to settle and the original diagnosis reconsidered first. Refilling immediately can obscure what the face actually needs and may recreate the same problem.
Can dissolving cause an allergic reaction?
Allergic and hypersensitivity reactions to hyaluronidase can occur. Previous reactions to hyaluronidase and a significant bee or wasp venom allergy should be discussed before elective treatment because they may affect the risk assessment. In an emergency filler complication, management priorities are different and should be determined clinically.
Do I need ultrasound before dissolving?
Not everyone does. Ultrasound can be valuable when the filler type or location is uncertain, when complications are suspected, or when targeted treatment would improve diagnostic confidence.
Where is filler dissolving available?
Face for Soul is based in Burford, Oxfordshire, welcoming patients from West Oxfordshire and across the Cotswolds. Assessment comes before treatment.